NP

Nechiyilthody Pfizer

Active Director Director DIN 10935070
DIN 10935070 First appointment Jan 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Nechiyilthody Pfizer

Data last updated:

Nechiyilthody Pfizer is a Director at Clapton Luxi International Private Limited (since 2026) and Designated Partner at Jawahar Ventures Llp (since 2025).

DIN 10935070
Primary Designation Director
First Appointment 31 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Jan 20262026Active
Designated Partner31 Jan 20252025Active

Board colleagues of Nechiyilthody Pfizer

Directorship timeline

Open interactive timeline →
Clapton Luxi International Private Limited
Jawahar Ventures Llp
Premium access

Shareholding and investment profile for Nechiyilthody Pfizer

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nechiyilthody Pfizer

Nechiyilthody Pfizer currently holds 2 directorships: Clapton Luxi International Private Limited (Director, since 20 Jan 2026); Jawahar Ventures Llp (Designated Partner, since 31 Jan 2025).

Nechiyilthody Pfizer was first appointed on 31 Jan 2025 as Designated Partner at Jawahar Ventures Llp. The most recent appointment on record is 20 Jan 2026 at Clapton Luxi International Private Limited.

The current boards of Nechiyilthody Pfizer's companies include Nishi Pfizer (Clapton Luxi International Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available